IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1040 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (498 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed261    
    Printed2    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTERS TO THE EDITOR - LETTER IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
Year : 2019  |  Volume : 85  |  Issue : 4  |  Page : 412-413

Author's reply


Consultant Dermatologist, Dr. Dashore's DHL Clinic, Indore, MP, India

Date of Web Publication7-Jun-2019

Correspondence Address:
Dr. Shuken Dashore
Consultant Dermatologist, Dr. Dashore's DHL Clinic, Indore, MP
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdvl.IJDVL_384_19

Rights and Permissions



How to cite this article:
Dashore S. Author's reply. Indian J Dermatol Venereol Leprol 2019;85:412-3

How to cite this URL:
Dashore S. Author's reply. Indian J Dermatol Venereol Leprol [serial online] 2019 [cited 2019 Sep 21];85:412-3. Available from: http://www.ijdvl.com/text.asp?2019/85/4/412/259379




Sir,

I would like to thank you for your interest in our case of two rare variants of dermatofibrosarcoma protuberans. You have rightly pointed out that there is an increased prevalence of this condition in HIV seropositive cases.[1] However, case 1 described in the letter to the editor had persistent slowly progressive lesion since the past 25 years with no history suggestive of HIV seropositivity occurring before the appearance of lesion and progression of the same over the period of 25 years.[2] You have also rightly stated that the incidence of HIV seroprevalence in India is higher than global average.[3] However, the case in discussion hails from Madhya Pradesh which is a low prevalence state for HIV.[4] Prevalence of HIV seropositivity in blood donors in the state of Madhya Pradesh was found to be 0.10%, which is lower than the global average (0.2%).[4] In view of the above factors, HIV testing was not undertaken. We agree with the argument that HIV testing must be done in cases of atypical cases of dermatofibrosarcoma protuberans especially in areas of high prevalence of HIV.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Sapadin AN, Gelfand JM, Howe KL, Phelps RG, Grand D, Rudikoff D, et al. Dermatofibrosarcoma protuberans in two patients with acquired immunodeficiency syndrome. Cutis 2000;65:85-8.  Back to cited text no. 1
    
2.
Jain S, Dashore S, Singhania B, Khopkar US, Darkase B. Dermatofibrosarcoma protuberans: Two rare variants. Indian J Dermatol Venereol Leprol 2019;85:204-8.  Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Paranjape RS, Challacombe SJ. HIV/AIDS in India: An overview of the Indian epidemic. Oral Dis 2016;22 Suppl 1:10-4.  Back to cited text no. 3
    
4.
Yadav UC, Sharma D, Shrivatava M, Jain A. Prevalence of HIV among blood donors at Madhya Pradesh, a central state of India. IOSR J Dent Med Sci 2018;17:57-64.  Back to cited text no. 4
    




 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow